MSB 2.22% $1.15 mesoblast limited

Ann: Ethics Approval to Treat COVID-19 Patients in Australia, page-160

  1. 107 Posts.
    lightbulb Created with Sketch. 83
    I don't think this says anything about progress on enrolled numbers. The process would have started months ago - probably some weeks for Monash Health to formally agree to take part, then more weeks to prepare and submit the ethics application, then several weeks for the application to go before a human research ethics committee. They may have asked for more info. Eventually it gets approved.

    So today is the day it gets announced - even if the trial closes fully enrolled with 300 patients tomorrow.

    Hopefully a few patients in Australia get in though. Good on many levels, not the least Australian medicos recognition of Mesoblast's credibility.
    Last edited by Larrynic: 02/09/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.15
Change
0.025(2.22%)
Mkt cap ! $1.313B
Open High Low Value Volume
$1.16 $1.19 $1.13 $8.289M 7.186M

Buyers (Bids)

No. Vol. Price($)
1 22569 $1.14
 

Sellers (Offers)

Price($) Vol. No.
$1.15 105374 2
View Market Depth
Last trade - 16.10pm 22/05/2024 (20 minute delay) ?
Last
$1.15
  Change
0.025 ( 2.46 %)
Open High Low Volume
$1.16 $1.19 $1.13 1229288
Last updated 15.59pm 22/05/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.